Live in-person:

6 - 9 February 2023

Dubai World Trade Centre

 16 Jan - 9 Mar 2023

Online


Clinical impact of accelerate pheno antimicrobial susceptibility in pediatric sepsis


Biorus

 

 Wednesday 8th February I 14:00 - 16:00

 Johannesburg room I Z1.D10

 

Overview


The healthcare professionals of Al Jalila Hospital will share with the audience their observation on septic patient treatment, laboratory data & changing treatment, and how to implement a fast track for sepsis patients and treat your critical patients in an urgent manner.

Learning objectives:

  • Introduction of an innovative method for the analysis of sepsis patients samples
  • How working directly from positive blood culture and delivering a fast ID & susceptibility will have therapy adjustments
  • Understand the impact of empiric therapy doses
  • Understand the impact on laboratory operations
  • Understand the impact on patient lives

Company bio


Biorus is a leading provider of medical and diagnostic solutions, laboratory equipment and technical services for clinical and research institutions across the MENA region. We offer flexible and customized solutions, as well as access to scientific education for individuals and stakeholders. We aim to maintain long-term relationships with clients and partners that are built on reliability, trust and loyalty. Our team is made up of multi-specialist, multinational experts that are not only highly experienced, but also have passion and love for what they do. Our wide range of product can accommodate to our client's needs through providing IVD molecular diagnostics, NGS, microbiology & haematology solutions. 

Presenter

 

Dr Rubina Lone
Acting Head of Department, Al Jalila Children’s Specialty Hospital

Dr. Rubina Lone is Director of Laboratory Medicine at Al Jalila Children’s and Clinical Adjunct Associate Professor at Mohammad Bin Rashid University. She is Diplomate American Board of Medical Microbiology with expertise in bacteriology, virology, mycology, parasitology, serology, immunology, molecular microbiology, health and safety. She is also a fellow of Canadian College of Microbiology. Dr. Rubina is a member of the Infection Control Committee, Point of Care Testing Committee and Quality and Safety Committee. She is also the quality and risk champion for Laboratory Medicine at Al Jalila Children’s. She is a member of the American Society of Microbiology and  member of the Royal College of Pathologists and has also presented and published her research in over 30 peer-reviewed publications.